A small new study suggests that people who’ve used GLP-1 drugs to reach a healthy weight can spread out their injections ...

Losing 4 pounds in a week isn’t unheard of, but it’s not usually considered a safe or sustainable strategy for weight loss.

Eli Lilly said on Thursday its experimental obesity drug helped patients lose as much as 20.1% of their weight in a mid-stage ...

Early weight loss of 2%-3% within 4 weeks is significantly linked to achieving clinically significant weight loss at 16 weeks ...

Eli Lilly has linked its amylin agonist eloralintide to up to 20.1% weight loss at Week 48, encouraging the drugmaker to ...

Microdosing GLP-1 weight loss drugs like semaglutide is trendy, with supporters touting benefits such as lower costs and potentially fewer side effects. But some doctors are skeptical, calling it ...

Here are five sustainable ways to finally lose weight – and keep it off – in the new year. The internet is full of promises: ...

Amylin is a peptide co-secreted with insulin in response to food intake. It controls gastric emptying, inhibits glucagon secretion, and promotes satiety. Several amylin receptor agonists are in ...

More work needs to be done to tease out the mechanisms by which GLP-1 RAs lower the risk of MACE, researchers say.